Product Name |
CAS No. |
DMF No. Status |
Specification |
Indication |
Anastrozole |
120511-73-1 |
US DMF No.19496 |
USP |
Oncology |
Aripiprazole* |
129722-12-9 |
US DMF No.19982 |
Available upon Request |
Schizophrenia |
Bosentan* |
147536-97-8 |
US DMF Pending |
Available upon Request |
Pulmonary Arterial Hypertension |
Capecitabine |
154361-50-9 |
US DMF No.22014 |
USP |
Oncology |
Carbinoxamine Maleate |
3505-38-2 |
US DMF No.21283 |
USP |
Antihistamines |
Erlotinib Hydrochloride* |
183319-69-9 |
US DMF No.23136 |
Available upon Request |
Oncology |
Glycopyrrolate |
596-51-0 |
US DMF No.21326 |
USP |
Peptic ulcer |
Imatinib Mesylate* |
220127-57-1 |
US DMF No.24838 |
Available upon Request |
Oncology |
Letrozole |
112809-51-5 |
US DMF No.20761
cDMF No. 2009-028 |
USP |
Oncology |
Mefenamic Acid |
61-68-7 |
US DMF No.20374 |
USP |
Pain and inflammation |
Memantine Hydrochloride |
41100-52-1 |
US DMF No.20151 |
Available upon Request |
Alzheimer's |
Rasagiline Mesylate* |
161735-79-1 |
US DMF No. 21283 |
Available upon Request |
Parkinson's |
Tamsulosin Hydrochloride |
106463-17-6 |
US DMF No.18067 |
USP,EP |
Benign Prostatic Hyperplasia |
*Products are only available in designated territories due to pending patent clarification. |